Skip to main content
Menu
US

Revvity Blog

Powering innovation from discovery to cure.

Unraveling the power of unique molecular identifiers in cancer research.
NGS - 2 min read
Biologics
The automation challenge of ‘Bioprocess 4.0’.
Biologics
White paper: screening and characterization of multi-specific antibody therapeutics.
Biologics
Offsetting COVID-19 staffing limitations in a laboratory: improving workflow efficiency via shorter assay workflows.
Biologics
Challenges and strategies for characterization of next-generation bispecific antibodies.
Biologics
Bispecific antibodies: successes, challenges, and strategies.
Biologics
Researchers develop novel assay for simultaneous measurement of bsAb target binding.

Questions?
We’re here to help.

Contact us